Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8672)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Elshamy M, Aucejo F, Menon KVN, Eghtesad B. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria. World J Hepatol 2016; 8(21): 874-880 [PMID: 27478537 DOI: 10.4254/wjh.v8.i21.874] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i21/874.htm |
| Number | Citing Articles |
| 1 |
Armin Finkenstedt, Maria Effenberger, Heinz Zoller. Lebertransplantation: Indikationen und Abklärung. Journal für Gastroenterologische und Hepatologische Erkrankungen 2018; 16(4): 112 doi: 10.1007/s41971-018-0038-6
|
| 2 |
Yunseon Choi, YoungKil Choi, Chang Soo Choi, Yun-Han Lee. Diabetes Mellitus Increases the Risk of Intrahepatic Recurrence of Hepatocellular Carcinoma after Surgical Resection. Tumori Journal 2017; 103(3): 279 doi: 10.5301/tj.5000594
|
| 3 |
Young Kim, Christopher C. Stahl, Abouelmagd Makramalla, Olugbenga O. Olowokure, Ross L. Ristagno, Vikrom K. Dhar, Michael R. Schoech, Seetharam Chadalavada, Tahir Latif, Jordan Kharofa, Khurram Bari, Shimul A. Shah. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Surgery 2017; 162(6): 1250 doi: 10.1016/j.surg.2017.08.007
|
| 4 |
Chandrashekhar Kubal, Plamen Mihaylov, John Holden. Oncologic indications of liver transplantation and deceased donor liver allocation in the United States. Current Opinion in Organ Transplantation 2021; 26(2): 168 doi: 10.1097/MOT.0000000000000866
|
| 5 |
Dong Jin Joo, Do Young Kim, Jinsil Seong, Hyun Jeong Kim, Jae Geun Lee, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim. Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report. Journal of Liver Cancer 2021; 21(2): 181 doi: 10.17998/jlc.2021.09.08
|
| 6 |
Huixin Li, Zhanyu Yang, Ruofan Li, Shichun Lu, Wenping Lu. Regorafenib Combined With Sirolimus Achieves Successful Treatment of Diffuse Double Lung Metastasis After Liver Transplantation in Giant Liver Cancer Beyond Transplantation Criteria: A Case Report. Transplantation Proceedings 2020; 52(2): 634 doi: 10.1016/j.transproceed.2019.12.001
|
| 7 |
Charlotte E. Costentin, Yanik J. Bababekov, Andrew X. Zhu, Heidi Yeh. Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased‐Donor Liver Transplantation?. Hepatology 2019; 69(3): 1324 doi: 10.1002/hep.30278
|
| 8 |
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
|
| 9 |
Raphael Iglesias de Oliveira Vidal, Edison Iglesias de Oliveira Vidal, Basilio de Bragança Pereira, Cachimo Combo Assane, Alexandre Ribeiro, Emilia Matos do Nascimento, Fernando Gomes Romeiro, Joaquim Ribeiro Filho, Ran Wang. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1487593
|
| 10 |
Nitin N. Katariya, Blanca C. Lizaola-Mayo, David M. Chascsa, Emmanouil Giorgakis, Bashar A. Aqel, Adyr A. Moss, Pedro Luiz Serrano Uson Junior, Mitesh J. Borad, Amit K. Mathur. Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation. Cancers 2022; 14(9): 2056 doi: 10.3390/cancers14092056
|
| 11 |
G. Martínez-Mier, S. Esquivel-Torres, I.E. Casanova-Sánchez, A.Y. Escobar-Ríos, J.M. Troche-Gutiérrez, C.A. Yoldi-Aguirre. Hepatocellular carcinoma in the noncirrhotic liver: Clinical features and outcomes in Veracruz, Mexico. Revista de Gastroenterología de México (English Edition) 2021; 86(1): 4 doi: 10.1016/j.rgmxen.2019.11.006
|
| 12 |
Nima Kokabi, Nariman Nezami, Minzhi Xing, Johannes M Ludwig, Mario Strazzabosco, Hyun S Kim. Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma. Journal of Comparative Effectiveness Research 2019; 8(12): 993 doi: 10.2217/cer-2019-0076
|
| 13 |
Tomoki Ryu, Yuko Takami, Yoshiyuki Wada, Hideki Saitsu. Oncological Outcomes of Operative Microwave Ablation for Intermediate Stage Hepatocellular Carcinoma: Experience in 246 Consecutive Patients. Journal of Gastrointestinal Surgery 2022; 26(6): 1178 doi: 10.1007/s11605-022-05254-8
|
| 14 |
Angela Hill, Franklin Olumba, William Chapman. Transplantation for Hepatocellular Carcinoma. Surgical Clinics of North America 2024; 104(1): 103 doi: 10.1016/j.suc.2023.09.002
|
| 15 |
Berend R. Beumer, Jeroen L.A. van Vugt, Gonzalo Sapisochin, Peter Yoon, Marco Bongini, Di Lu, Xiao Xu, Paolo De Simone, Lorenzo Pintore, Nicolas Golse, Malgorzata Nowosad, William Bennet, Emmanouil Tsochatzis, Evangelia Koutli, Fariba Abbassi, Marco P.A.W. Claasen, Manuela Merli, Joanne O'Rourke, Martina Gambato, Alberto Benito, Avik Majumdar, Ek Khoon Tan, Maryam Ebadi, Aldo J. Montano‐Loza, Marina Berenguer, Herold J. Metselaar, Wojciech G. Polak, Vincenzo Mazzaferro, Jan N.M. IJzermans. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria. Journal of Cachexia, Sarcopenia and Muscle 2022; 13(5): 2373 doi: 10.1002/jcsm.13053
|
| 16 |
Benjamin P.T. Loveday, Arash Jaberi, Carol-Anne Moulton, Alice C. Wei, Steven Gallinger, Robert Beecroft, Sandra Fischer, Anand Ghanekar, Ian McGilvray, Gonazolo Sapisochin, Paul D. Greig, Kongteng Tan, Sean P. Cleary. Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma. HPB 2019; 21(8): 1072 doi: 10.1016/j.hpb.2018.12.009
|
| 17 |
G. Martínez-Mier, S. Esquivel-Torres, I.E. Casanova-Sánchez, A.Y. Escobar-Ríos, J.M. Troche-Gutiérrez, C.A. Yoldi-Aguirre. Carcinoma hepatocelular en hígado no cirrótico: características clínicas y resultados en Veracruz, México. Revista de Gastroenterología de México 2021; 86(1): 4 doi: 10.1016/j.rgmx.2019.11.007
|
| 18 |
Javier Ros, Francesc Salva, Cristina Dopazo, Daniel López, Nadia Saoudi, Iosune Baraibar, Ramon Charco, Josep Tabernero, Elena Elez. Liver transplantation in metastatic colorectal cancer: are we ready for it?. British Journal of Cancer 2023; 128(10): 1797 doi: 10.1038/s41416-023-02213-1
|
| 19 |
Ashwini Arvind, Karim Seif El Dahan, Riya Malhotra, Darine Daher, Nicole E. Rich, Madhukar S. Patel, Lisa B. VanWagner, Sarah R. Lieber, Thomas G. Cotter, Jeremy Louissaint, Arjmand R. Mufti, Laura Kulik, Anjana Pillai, Neehar D. Parikh, Amit G. Singal. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis. Liver Transplantation 2024; 30(6): 595 doi: 10.1097/LVT.0000000000000357
|
| 20 |
Abuzer Dirican, Serdar Karakas. What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?. Journal of Gastrointestinal Cancer 2020; 51(4): 1148 doi: 10.1007/s12029-020-00490-0
|
| 21 |
Judy Squires, Abhay Srinivasan, M. Beth McCarville. Contrast-Enhanced Ultrasound in Pediatric Imaging. 2021; : 205 doi: 10.1007/978-3-030-49691-3_18
|